Saturday, May 18th
Last update03:01:31 AM GMT
Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
 Up to one in five American youngsters – some 7 million to 12 million by one... |
 The Obama administration on Monday filed a last-minute appeal to delay the sale of the morning-after... | ||
 For almost a decade, the United States has been standing in the way of an idea... |
 The World Health Organization says it appears likely that the novel coronavirus (NCoV) can be passed... |
